Lexicon Pharmaceuticals (LXRX) Accounts Payables: 2009-2011
Historic Accounts Payables for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to $6.0 million.
- Lexicon Pharmaceuticals' Accounts Payables fell 22.08% to $4.3 million in Q3 2012 from the same period last year, while for Sep 2012 it was $4.3 million, marking a year-over-year decrease of 22.08%. This contributed to the annual value of $6.0 million for FY2011, which is 91.26% up from last year.
- Latest data reveals that Lexicon Pharmaceuticals reported Accounts Payables of $6.0 million as of FY2011, which was up 91.26% from $3.2 million recorded in FY2010.
- Over the past 5 years, Lexicon Pharmaceuticals' Accounts Payables peaked at $6.0 million during FY2011, and registered a low of $3.2 million during FY2010.
- In the last 3 years, Lexicon Pharmaceuticals' Accounts Payables had a median value of $5.9 million in 2009 and averaged $5.0 million.
- As far as peak fluctuations go, Lexicon Pharmaceuticals' Accounts Payables plummeted by 46.63% in 2010, and later soared by 91.26% in 2011.
- Lexicon Pharmaceuticals' Accounts Payables (Yearly) stood at $5.9 million in 2009, then slumped by 46.63% to $3.2 million in 2010, then surged by 91.26% to $6.0 million in 2011.